AnheuserBusch InBev Shares Dip as Quarterly Sales Fall Short of Analyst Expectations SP 500 Edges Higher on Broad Gains Healthcare Leads Japan China Trade Chiefs Hold First Direct Talks at APEC Since Escalated Trade Dispute Broadcom Meta and Industry Partners Invest 125 Million in Semiconductor Research Hub at UCLA Trump Signals Progress on Iran Deal and Strait of Hormuz Reopening Amid Ongoing Negotiations Jim Cramer Analyzes NVIDIAs Recent Earnings Key Takeaways from the Quarter Imperial Petroleum Inc 875 Series A Cumulative Redeemable Perpetual Preferred Shares IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on 67 Beat CLDX Q1 2026 Earnings Clinicalstage biotech reports widerthanexpected loss as pipeline investment continues MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline TIMB Q1 2026 Earnings EPS Misses Estimates by 1156 Despite Modest Stock Uptick FBIN Q1 2026 Earnings Slight EPS Miss as Housing Headwinds Persist Shares Edge Higher Quince Therapeutics Inc QNCX Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Over 200 Iterum Therapeutics ITRM Holds at 003 as Trading Volume Remains Subdued ACV Auctions ACVA Holds Steady Near Support as Market Awaits Direction Perion Network PERI Tests Key Support After 36 Decline Travel Leisure Co TNL Edges Higher Amid Resilient Travel Demand Nakamoto Inc NAKA Surges 915 Breaking Above Key Resistance Levels Taiwan Says No Timetable for US Chip Tariffs Preferential Terms Agreed ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress Volato Group SOAR Slides 523 as Selling Pressure Persists Near Key Support Apollo Global Management APO Slides 126 as Broader Market Pressures Weigh Bitdeer Technologies BTDR Gains 314 as Bullish Momentum Builds Kinross Gold KGC Steps Back from Resistance Support Levels in Focus Natuzzi NTZ Declines 32 as Stock Nears Key Support Level Texas Community Bancshares Inc TCBS Slips 059 as Stock Tests Key Support Levels JinkoSolar JKS Slips 169 as Solar Sector Faces Headwinds Key Support in Focus ProQR Therapeutics Holds Steady Above Support Small Uptick Signals Stability